Fluad
Details for Fluad vaccine and its components.
Sponsor:
Seqirus
Administration route:
Intramuscular injection, Subcutaneous injection
Vaccine group:
Adults aged ≥65 years only
Registered for use in people aged ≥65 years.
Adjuvanted trivalent inactivated influenza vaccine
Each 0.5 mL monodose pre-filled syringe contains:
- 15 µg haemagglutinin of each of the 3 recommended influenza virus strains.
These are adjuvanted with MF59C.1. The adjuvant includes:
- 9.75 mg squalene
- 1.175 mg polysorbate 80
May contain traces of:
- kanamycin
- neomycin
- formaldehyde
- barium sulfate
- cetyltrimethylammonium bromide
- ovalbumin
- latex
For full details, refer to the product information and consumer medicine information sheets for Fluad vaccine available on the TGA website.
Page history
Last updated:
23 April 2019
Last reviewed:
23 April 2019
Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/vaccines/fluad.